Type of Study:
Single treatment group to evaluate the amount of time the sensor glucose values from CGM are within target range with 12 weeks of LY900014
Study Length:
12 Weeks
Target Age/Sex:
over 18 years, Male and Female
Benefits:
Participants will receive at no cost: study product, study materials and study-specific procedures
Staus: Enrolling
Description:
This is a study of LY900014 in participants with Type 2 Diabetes using Continuous Glucose Monitoring.
